CHICAGO, March 4, 2015 - Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that Stacy Enxing Seng has been elected to its Board of Directors. She most recently served as an Executive in Residence for Covidien, as well as President of Covidien's Vascular Therapies Division from 2012 to 2014, and President of Peripheral Vascular from 2010 to 2012.
CHICAGO, March 4, 2015 - Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2015 second quarter dividend of $0.16 per share. The dividend is payable on March 31, 2015 to shareholders of record as of the close of business on March 17, 2015. This quarterly dividend represents a 5 percent increase over the amount paid a year ago as well as the amount paid last quarter. The annualized dividend rate per share will increase to $0.64 from $0.61.
CHICAGO, Feb. 3, 2015 - Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its fiscal first quarter ended December 31, 2014 and updated its fiscal year 2015 financial outlook. Adjusted earnings per diluted share of $0.49 increased 36 percent from $0.36 in the prior year, while reported earnings per diluted share of $0.21 decreased 5 percent from $0.22. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
CHICAGO, Jan. 14, 2015 - Hill-Rom Holdings, Inc. (NYSE: HRC) today announced preliminary unaudited revenue for its fiscal first quarter of 2015.
CHICAGO, Jan. 7, 2015 - Hill-Rom Holdings, Inc. (NYSE:HRC) will hold its fiscal 2015 first quarter earnings conference call and webcast from 8:00 a.m. - 9:00 a.m. ET on the morning of Tuesday, February 3, 2015.